Annexon, Inc. (ANNX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$4.87+0.62%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ANNX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 174.7 | 184.7 | 119.4 | 113.8 | 112.5 | 100.1 | 49.3 |
| Operating Income | (210.6) | (216.4) | (154.1) | (143.7) | (145.6) | (130.7) | (63.5) |
| Earnings from Continuing Operations | |||||||
| EBT, Incl. Unusual Items | — | (206.7) | 138.2 | 134.2 | 141.9 | 130.3 | (63.4) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | — | — |
| Net Income | |||||||
| Net Income | (202.7) | (206.7) | (138.2) | (134.2) | (141.9) | (130.3) | (63.4) |
| Per Share | |||||||
| Basic EPS | (1.01) | (1.34) | (1.01) | (1.77) | (2.60) | (3.40) | — |
| Diluted EPS | (1.01) | (1.34) | (1.01) | (1.77) | (2.60) | (3.40) | — |
| Dividend per Share | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Avg Shares | 201.0 | 155.1 | 137.4 | 75.7 | 54.7 | 38.3 | — |
| Diluted Weighted Avg Shares | 201.0 | 155.1 | 137.4 | 75.7 | 54.7 | 38.3 | — |
| Supplemental | |||||||
| EBITDA | — | (214.2) | (151.9) | (141.6) | (143.5) | (128.6) | (62.8) |
| EBIT | (210.6) | (216.4) | (154.1) | (143.7) | (145.6) | (130.7) | (63.5) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.